The price was “way lower than the market value” (according to seller 😁) It’s Verbsurgical backed by Alphabet & J&J. They’re burning cash like crazy. Apparently, G and J&J are buying the stock. @VerbSurgical
How can I buy some?:)
Just jump the 🚢 to Verb. You’ll get a raise and plenty of stock options 😁
How is the work there? How much collaboration with Verily/Google?
Will take forever and intuitive have 25 years ahead in game getting that goodwill , market capture, fda approval, patents and very high margin cash generating business is long way to go. Isrg is zero debt and over 6b cash and they are going beyond surgery already with robotic catheter and beyond while Google either way failed in most of the ventures you name it in robotics to automated to bio backed ventures and it is hardware where most stress is software I don’t know how much difference will they make out of it. No biased view purely based of facts and truths
The market will allow a few key players. Verb will be one. Provided that it could get rid of the many bad bosses and succeeded in keeping the brilliant eng. (afaik, they’ve been failing 😁).
Medtronic is better place and ahead of the game can’t get fda approval though :-( followed by transentrix in the competition but Isrg enjoyed monopoly and continue for real long till they innovate but with the increasing competition in this space, it would interesting to see other companies will make their fair share. I know few folks who went to Verb and came back to intuitive bitching about leadership but I hope leftover folks in there in leadership don’t chock up smart engineers as google is always bad in joint ventures and joint leadership. I love to see what they do with big data fuss and machine learning on a validated system that plays with human life. FDA will bring blood from the butt
Being late a few years is not a problem as long as the robot is innovative. (Remember Nokia vs Apple) Afaik, Verb robot is much better than transentrix. (Not sure abt Medtronic) Agree that Google is not good at joint ventures. Because It’s good at taking the upper hand 😁(i.e a win-lose deal). Until it understands what is a win-win deal, it will not have great success at jv
Agreed, but this is not Nokia and it is not about making a phone, end of the day, these are highly precise devices playing with human life (directly). Innovation burns money but stable capital generation model, high margin with low liability will take a real long. In innovation Intuitive is at par with peers, they own humungous patents on design and have upper hand in this space for so long. We file more patents than any of our peers combined with over ~900 doctorates in few labs in Sunnyvale and highest retention of average 6years. Recently one product now public came out of our labs, which an articulating, robotic‑assisted catheter will allow navigation along a planned path through the airways to a predetermined location. The catheter's size and maneuverability will allow it to pass through small and difficult‑to‑reach pathways in the periphery of the lung. This new, minimally‑invasive technology to obtain tissue samples of the lung. https://intuitivesurgical.com/davinci-innovation/
That means buying to keep the company afloat, not a good investment to buy right now.
Which company are you talking about ?
Verb
Yes. Da Vinci robots are very popular already, but are far behind in terms of software and are slow to iterate (same models for a decade), and yet ISRG market cap is 50B. If Verb valuation is less than 20B, then go for it. YMMV I know nothing about the industry or business...
Afaik, Verb is even slower. Getting a robot through FDA takes time